MEDICLINIC INTERNATIONAL LIMITED - Mediclinic acquires pathology laboratory operations in Dubai

Mediclinic acquires pathology laboratory operations in Dubai

Mediclinic International Limited

(Incorporated in the Republic of South Africa)

(Registration number: 1983/010725/06)

ISIN: ZAE000074142

Share Code: MDC

("Mediclinic")



MEDICLINIC ACQUIRES PATHOLOGY LABORATORY OPERATIONS IN DUBAI



Mediclinic announces the acquisition of the two pathology

laboratories at Mediclinic Welcare Hospital and Mediclinic Al

Sufouh in Dubai for a cash consideration of AED95 million (R262

million) with effect from 1 October 2013.



The acquisition is expected to add AED19 million of annualised

incremental Earnings before Interest, Taxation, Depreciation and

Amortisation (EBITDA).



The acquisition supports the strategy of Mediclinic Middle East to

establish a centralised and reference laboratory that will yield

operational and clinical benefits.



Stellenbosch

21 November 2013



Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa

PO Box 456, Stellenbosch 7599, South Africa

Tel +27 (0)21 809 6500

Fax +27 (0)21 886 4037

Ethics Line: 0800 005 316

Website: www.mediclinic.com



Sponsor

RAND MERCHANT BANK (A division of FirstRand Bank Limited)


Date: 21/11/2013 02:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.